Your browser doesn't support javascript.
loading
Hypercalcaemia - presentation and management .
Turner, Jeremy J O.
Afiliación
  • Turner JJO; Department of Diabetes & Endocrinology, Norfolk and Norwich University Hospital; Norwich Medical School; NIHR CRN:Eastern Research Network, Norwich, UK. jeremy.turner@nnuh.nhs.uk.
Clin Med (Lond) ; 17(3): 270-273, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28572230
ABSTRACT
Hypercalcaemia is a common disorder normally caused by primary hyperparathyroidism (PHPT) or malignancy. A proportion of cases present as an emergency, which carries a significant mortality. Emergency management of hypercalcaemia is based on intravenous rehydration with normal saline but when this is inadequate, bisphosphonate therapy is used; more recently the novel anti-resorbtive agent denosumab has been shown to have a useful role in treatment. It is estimated that up to 10% of all cases of PHPT presenting under the age of 45 years have an underlying genetic predisposition; nine potentially causative genes are now recognised and may be screened in routine clinical practice. Although parathyroidectomy is the only curative treatment for PHPT, this is indicated in a minority of cases. Many cases can be adequately managed conservatively and guidance from the 4th international workshop on the management of asymptomatic PHPT has recently been updated in a consensus statement.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipercalcemia Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Clin Med (Lond) Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipercalcemia Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Clin Med (Lond) Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido